Clinical relevance of 201tl-chloride spet in the differential diagnosis of brain tumours

Nuclear Medicine Communications

Volumn 19, Issue 4, 1998, Pages 335-340

  Staffen, W ^a   Hondl, N ^a   Trinka, E ^a   Iglseder, B ^a   Unterrainer, J ^a   Ladurner, G ^a  

^a Salzburger Landeskliniken   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; THALLIUM; THALLIUM CHLORIDE TL 201;

ADULT; AGED; ARTICLE; BRAIN TUMOR; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; FEMALE; HEMISPHERIC DOMINANCE; HUMAN; MALE; MIDDLE AGED; SCINTILLATION CAMERA; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ASTROCYTOMA; BRAIN ISCHEMIA; BRAIN METASTASIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GLIOMA; INTRAVENOUS DRUG ADMINISTRATION; MENINGIOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; TUMOR NECROSIS; TUMOR VASCULARIZATION;

ADULT; AGED; BRAIN NEOPLASMS; CEREBROVASCULAR DISORDERS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FUNCTIONAL LATERALITY; GAMMA CAMERAS; HUMANS; MALE; MIDDLE AGED; TECHNETIUM TC 99M EXAMETAZIME; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031593656     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199804000-00007     Document Type: Article

References (31)

1. Friedman WA, Sceat DJ Jr, Nestok BR et al. The incidence of unexpected pathological findings in an image guided biopsy series: A review of 100 cases. Neurosurgery 1989; 25: 180-184.
2. Chamberlain MC, Murovic JA, Levin VA. Absence of contrast enhancement on CT brain scans of patients with supra tentorial malignant gliomas. Neurology 1988; 38: 1371-1374.
3. Gruber ML, Hachberg FH. Systemic evaluation of primary brain tumours. J NucI Med 1990; 31: 969-971.
4. Kim KT, Black KT, Marciano D. Thallium-201 SPECT imaging of brain tumours: Methods and results. J Nucl Med 1990; 31: 965-969.
5. Oriuchi N, Tamura M, Shibazaki T et al. Clinical evaluation of thallium-201 SPECT in supratentorial glioma: Relationship to histological grade, prognosis and proliferative activities. J. Nucl Med 1993; 34: 2089-2090.
6. Kasarov LB, Friedman H. Enhanced Na+-K+-activated adenosine triphosphatase activity in transformed fibroblasts. Cancer Res 1974; 34: 1862.
7. Ancri D, Bassett JY, Louchampt MF et al. Diagnosis of cerebral lesions of 201ThalIium. Nuklearmedizin 1978; 128: 417.
8. Black KL, Emerick T, Hoh C et al. Thallium-201 SPECT and positron emission tomography are equal predictors of glioma grade and recurrence. Neurol Res 1994; 16: 93-96.
9. Kosuda S, Aoki S, Suzuki K et al. Re-evaluation of quantitative thallium-201 brain SPECT for brain tumour. J Nad Med 1992; 33: 844.
10. Sjoholm H, Brun A, Elenqvist D et al. Thallium-201 and SPECT distinguishes high-grade from low-grade gliomas. ] Nucl Med 1992; 33: 868.
11. Kaplan WD, Takvorian T, Morris JH et al. Thallium-201 brain tumor imaging: A comparative study with pathologic correlation. ] Nucl Med 1987; 28: 47.
12. Antar MA, Barnett GH, Quigley MR et al. Comparison of brain thallium-201-SPECT and fluor-18-FDG-PET in detecting recurrent brain tumors in the presence of radiation necrosis. Eur J Nucl Med 1993; 20: 819.
13. Hoh CK, Khauma S, Harris GC et al. Evaluation of brain tumor recurrence with Tl201 SPECT studies: Correlation with FDG-PET and histological results, J Nucl Med 1992; 33: 867.
14. Dierckx RA, Martin JJ, Dobbeleir A et al. Sensitivity and specifity of thallium-201 single photon emission tomography in the functional detection and differential diagnosis of brain tumours. Eur J Nucl Med 1994; 21: 621-633.
15. Prat-Acin R, Diaz-Vicente J, Banzo J et al. The use of SPECT with 201-Tl in the evaluation of brain tumors. Rev Neurol 1996; 24: 909-913.
16. Yoshii Y, Satou M, Yamamoto T et al. The role of thallium-201 single photon emission tomography in the investigation and characterisation of brain tumours in man and their response to treatment. Eur J Nucl Med 1993; 20: 39-45.
17. Abdel-Dayem H. 201-Tl-chloride uptake ratios in differentiating benign from malignant lesions: Recommendations for ratio calculations and interpretation. Nucl Med Commun 1995; 16: 188-195.
18. Igase K, Oka Y, Ohta S et al. Usefulness of thallium-201 single photon emission computed tomography to quantify the malignancy grade of brain tumors. Neurol Med Chir 1996; 36: 434-439.
19. Rubinstein R, Karger H, Pietrzyk U et al. Use of 201-thallium brain SPECT, image registration, and semi-quantitative analysis in the follow-up of brain tumors. Eur J Radiol 1996; 21: 188-195.
20. Slizofski WJ, Krishna L, Katsetos CD et al. Thallium imaging for brain tumors with results measured by a semi-quantitative index and correlated with histopathology. Cancer 1994; 74: 317-320.
21. Burkard R, Kaiser KP, Wieler H et al. Contribution of thallium-201-SPECT to the grading of tumorous alterations of the brain. Neurosurg Rev 1992; 15: 265-273.
22. Sjoholm H, Elmquist D, Rehncrona S et al. SPECT imaging of gliomas with thallium-201 and technetium-99m-HMAPO. Acta Neurol Scand 1995; 91: 66-70.
23. Kallen K, Heiling M, Andersson AM et al. Preoperative grading of glioma malignancy with thallium-201 single photon emission CT: Comparison with conventional CT. Am J Neuroradiol 1996; 17: 925-932.
24. Relationship between thallium-201 uptake by supra-tentorial glioblastomas and their morphological characteristics on magnetic resonance imaging. Eur J Nucl Med 1996; 23: 524-529.
25. Kosuda S, Fujii H, Aoki S et al. Reassessment of quantitative thallium-201 brain SPECT for miscellaneous brain tumors. Ann Nucl Med 1993; 7: 257-263.
26. Ueda T, Kaji Y, Wakisaka S et al. Time sequential single photon emission computed tomography studies in brain tumor using thallium-201. Eur J Nucl Med 1993; 20: 138-145.
27. Madison MT, Hall WA, Latchaw RE et al. Radiologic diagnosis, staging, and follow-up of adult central nervous system primary malignant glioma. Radiol Clin North Am 1994; 32: 183-196.
28. Moody EB, Hodes JE, Walsh JW et al. Thallium-avid cerebral radiation necrosis. Clin Nucl Med 1994; 19: 611-613.
29. Moustafa HM, Oman WM, Ezzat I et al. 201-T1 single photon emission tomography in the evaluation of residual and recurrent astrocytoma. Nucl Med Commun 1994; 15: 140-143.
30. Nakamura O, Kosuda S, Okamoto K et al. Differential diagnosis between recurrence of gliomas and radiation necrosis by 201-Tl-chloride SPECT. No To Shinkei 1994; 46: 1051-1057.
31. Ruiz A, Ganz WI, Post MJ et al. Use of thallium-201 brain SPECT to differentiate cerebral lymphoma from toxoplasma encephalitis in AIDS patients. Am J Neuroradiol 1994; 15: 1885-1894.